A POST-HOC ANALYSIS EXPLORING PARTICIPANT-LEVEL TRAJECTORIES OF COGNITIVE PERFORMANCE AMONG PATIENTS WITH SCHIZOPHRENIA IN A MULTI-NATIONAL PHASE II TRIAL

被引：0
|
作者：
Granger, Kiri [1 ]
Cotter, Jack [1 ]
Baker, Elizabeth [1 ]
Barnett, Jenny [1 ]
Sand, Michael [2 ]
机构：
[1] Cambridge Cognit, Cambridge, England
[2] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
来源：
SCHIZOPHRENIA BULLETIN | 2019年 / 45卷
关键词：
D O I：
10.1093/schbul/sbz022.134
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
32.3
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 19 条
  • [1] EXPLORING PARTICIPANT-LEVEL TRAJECTORIES OF COGNITIVE PERFORMANCE AMONG PATIENTS WITH SCHIZOPHRENIA IN A MULTI-NATIONAL TRIAL
    Granger, Kiri
    Cotter, Jack
    Baker, Elizabeth
    Evenden, John
    Barnett, Jennifer
    Sand, Michael
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S353 - S353
  • [2] Exploring the norepinephrine to angiotensin II conversion ratio in patients with vasodilatory hypotension: A post-hoc analysis of the ARAMIS trial
    See, Emily J.
    Chaba, Anis
    Spano, Sofia
    Maeda, Akinori
    Clapham, Caroline
    Liu, Jasmine
    Khasin, Monique
    Liskaser, Grace
    Eastwood, Glenn
    Bellomo, Rinaldo
    JOURNAL OF CRITICAL CARE, 2024, 79
  • [3] KarXT treatment improves cognitive performance in cognitively impaired patients with schizophrenia: a post-hoc analysis of the phase 2 EMERGENT-1 study
    Sauder, C.
    Allen, L.
    Baker, E.
    Granger, K.
    Brier, A.
    Kavanagh, S.
    Marcus, R.
    Paul, S.
    Miller, A.
    Brannan, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S580 - S581
  • [4] Efficacy Of Rituximab In Patients With Refractory Lupus Nephritis, a Post-Hoc Analysis From Phase II Trial In Japan.
    Tanaka, Yoshiya
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Miyasaka, Nobuyuki
    Sumida, Takayuki
    Mimori, Tsuneyo
    Koike, Takao
    Endo, Kazuhiro
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S253 - S254
  • [5] High-level responses across multiple domains in patients with atopic dermatitis treated with abrocitinib versus dupilumab: a post-hoc analysis of a phase III randomized trial
    Armstrong, April W.
    Blauvelt, Andrew
    Gooderham, Melinda J.
    Hong, H. Chih-ho
    Zhang, Fan
    Feeney, Claire
    Clibborn, Claire
    Myers, Daniela E.
    Chan, Gary
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E125 - E125
  • [6] Encephaloduroarteriosynangiosis Averts Stroke in Atherosclerotic Patients With Border-Zone Infarct: Post Hoc Analysis From a Performance Criterion Phase II Trial
    Quintero-Consuegra, Miguel D.
    Toscano, Juan F.
    Babadjouni, Robin
    Nisson, Peyton
    Kayyali, Mohammad N.
    Chang, Daniel
    Almallouhi, Eyad
    Saver, Jeffrey L.
    Gonzalez, Nestor R.
    NEUROSURGERY, 2021, 88 (04) : E312 - E318
  • [7] Encephaloduroarteriosynangiosis Averts Stroke in Atherosclerotic Patients With Border-Zone Infarct: Post Hoc Analysis From a Performance Criterion Phase II Trial
    Quintero-Consuegra, Miguel D.
    Toscano, Juan F.
    Babadjouni, Robin
    Nisson, Peyton
    Kayyali, Mohammad N.
    Chang, Daniel
    Almallouhi, Eyad
    Saver, Jeffrey L.
    Gonzalez, Nestor R.
    NEUROSURGERY, 2021, 89 : S111 - S111
  • [8] Cartilage Thickness Modification with Sprifermin in Knee Osteoarthritis Patients Translates into Symptomatic Improvement over Placebo in Patients at Risk of Further Structural and Symptomatic Progression: Post-Hoc Analysis of a Phase II Trial
    Guehring, Hans
    Kraines, Jeffrey
    Moreau, Flavie
    Daelken, Benjamin
    Ladel, Christoph
    Wirth, Wolfgang
    Conaghan, Philip G.
    Eckstein, Felix
    Hochberg, Marc C.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] Encephaloduroarteriosynangiosis Averts Stroke in Atherosclerotic Patients With Border-Zone Infarct: Post Hoc Analysis From a Performance Criterion Phase II Trial COMMENT
    Carroll, Kate T.
    Kim, Louis J.
    NEUROSURGERY, 2021, 88 (04) : E318 - E318
  • [10] Commentary: Encephaloduroarteriosynangiosis Averts Stroke in Atherosclerotic Patients With Border-Zone Infarct: Post Hoc Analysis From a Performance Criterion Phase II Trial
    Raper, Daniel M. S.
    Abla, Adib A.
    NEUROSURGERY, 2021, 88 (04) : E319 - E320
12